Number of shares present or represented at the meeting (including abstentions): | 40,422,608 |
Number of issued shares: | 151,626,107 |
Percentage of issued shares present or represented at the meeting: | 26.66% |
Number of voting securities present or represented at the meeting (including abstentions) | 332,857,067 |
Number of issued voting securities | 454,878,321 |
Percentage of voting securities present or represented at the meeting | 73.17% |
Total number of shares and voting securities present or represented at the meeting (including abstentions): | 373,279,675 |
Item | Subject Matter | Number of votes cast FOR | % of votes cast FOR | Number of votes cast AGAINST | % of votes cast AGAINST | Abstentions | Total number of shares and voting securities present or represented |
First Item | Presentation of the special report of the board of directors of the Company (as required pursuant to Article 441-7 of the Luxembourg law of 10 August 1915 on commercial companies, | n/a | n/a | n/a | n/a | n/a | 373,279,675 |
as amended) on any transaction, since the last general meeting of the Company, in respect of which any of the directors declared to have an interest conflicting with that of the Company. | |||||||
Second Item | Presentation of (i) the combined management report of the board of directors of the Company in respect of the stand-alone annual financial statements of the Company and the consolidated financial statements of the Company and its group for the financial year ending 31 December 2022, (ii) the report of the independent auditor of the Company in respect of the stand-alone annual financial statements of the Company and its group for the financial year ending 31 December 2022 and (iii) the report of the independent auditor of the Company in respect of the consolidated financial statements of the Company and its group for the financial year ending 31 December 2022. | n/a | n/a | n/a | n/a | n/a | 373,279,675 |
Third Item | Approval of the audited stand-alone annual financial statements of the Company for the financial year ending 31 December 2022. | 350,212,068 | 96,08% | 14,300,000 | 3,92% | 8,767,607 | 373,279,675 |
Fourth Item | Approval of the audited consolidated financial statements of the Company and its group for the financial year ending 31 December 2022 | 350,212,068 | 96,08% | 14,300,000 | 3,92% | 8,767,607 | 373,279,675 |
Fifth Item | Re-approval of the allocation of the statutory financial results for the financial year ending 31 December 2022 | 350,212,068 | 96,08% | 14,300,000 | 3,92% | 8,767,607 | 373,279,675 |
Sixth item | Presentation of (i) the combined management report of the board of directors of the Company in respect of the stand-alone annual financial statements of the Company and the consolidated financial statements of the Company and its group for the financial year ending 31 December 2023, (ii) the report of the independent auditor of the Company in respect of the stand-alone annual financial statements of the Company and its group for the financial year ending 31 December 2023 and (iii) the report of the independent auditor of the Company in respect of the consolidated financial statements of the Company and its group for the financial year ending 31 December 2023. | 8,767,608 | 96,08% | 14,300,000 | 3,92% | 8,767,607 | 373,279,675 |
Seventh Item | Approval of the stand-alone audited annual financial statements of the Company for the financial year ending 31 December 2023. | 350,212,067 | 96,08% | 14,300,001 | 3,92% | 8,767,607 | 373,279,675 |
Eight Item | Approval of the audited consolidated financial statements of the Company and its group for the financial year ending 31 December 2023. | 340,224,802 | 93,34% | 24,287,266 | 6,66% | 8,767,607 | 373,279,675 |
Ninth Item | Re-approval of the allocation of the statutory financial results for the financial year ending 31 December 2023. | 350,212,068 | 96,08% | 14,300,000 | 3,92% | 8,767,607 | 373,279,675 |
Tenth Item | Granting of discharge (quitus) to all directors of the Company who held office during the financial year ending 31 December 2022 in respect of the performance of their duties during that financial year. | 339,644,810 | 93,18% | 24,867,258 | 6,82% | 8,767,607 | 373,279,675 |
Eleventh Item | Confirmation of granting of discharge (quitus) to all directors of the Company who held office during the financial year ending 31 December 2023 in respect of the performance of their duties during that financial year. | 339,522,226 | 93,14% | 24,989,842 | 6,86% | 8,767,607 | 373,279,675 |